Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook

Publish Date: May 2019 | Category: Biotechnology | Publisher: BCC Research | Status: Publish

The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024.

Report Scope:

The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.

The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.

The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

- 28 data tables
- An overview of global markets for stem cell and regenerative medicines
- Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Details of historic background and description of embryonic and adult stem cells
- Information on stem cell banking and stem cell research
- A look at the growing research & development activities in regenerative medicine
- Coverage of ethical issues in stem cell research & regulatory constraints on biopharmaceuticals
- Comprehensive company profiles of key players in the market, including Aldagen Inc., Caladrius Biosciences Inc., Daiichi Sankyo Co. Ltd., Gamida Cell Ltd. and Novartis AG

Summary

The global market for stem cell and regenerative medicines was valued at REDACTED billion in 2018. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED billion by 2024. Growth of the global market is attributed to the factors such as growingprevalence of cancer, technological advancement in product, growing adoption of novel therapeuticssuch as cell therapy, gene therapy in treatment of chronic diseases and increasing investment fromprivate players in cell-based therapies.

In the global market, North America held the highest market share in 2018. The Asia-Pacific region is anticipated to grow at the highest CAGR during the forecast period. The growing government funding for regenerative medicines in research institutes along with the growing number of clinical trials based on cell-based therapy and investment in R&D activities is expected to supplement the growth of the stem cell and regenerative market in Asia-Pacific region during the forecast period.

Reasons for Doing This Study

Global stem cell and regenerative medicines market comprises of various products for novel therapeutics that are adopted across various applications. New advancement and product launches have influenced the stem cell and regenerative medicines market and it is expected to grow in the near future. The biopharmaceutical companies are investing significantly in cell-based therapeutics. The government organizations are funding research and development activities related to stem cell research. These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand of stem cell and regenerative therapy among different application segments. The market is impacted through adoption of stem cell therapy. The key players in the market are investing in development of innovative products. The stem cell therapy market is likely to grow during the forecast period owing to growing investment from private companies, increasing in regulatory approval of stem cell-based therapeutics for treatment of chronic diseases and growth in commercial applications of regenerative medicine.

Products based on stem cells do not yet form an established market, but unlike some other potential applications of bioscience, stem cell technology has already produced many significant products in important therapeutic areas. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its current practical applications, evaluate the participating companies and look to its future.

The report provides the reader with a background on stem cell and regenerative therapy, analyzes the current factors influencing the market, provides decision-makers the tools that inform decisions about expansion and penetration in this market.

Table of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background
Overview: Cells
Overview: Stem Cell
Embryonic Stem Cell (ES)
Growth and Identification of Embryonic Stem Cells
Stimulating Embryonic Stem Cells to Differentiate
Adult Stem Cell
Mesenchymal Stem Cells
Hematopoietic Stem Cells
Neural Stem Cell 
Endothelial Progenitor Cell
Epithelial Stem Cell
Very Small Embryonic-Like Cell 
Cord Blood Stem Cell
Induced Pluripotent Stem Cells
Evolution of Induced Pluripotent Stem Cell Research
Advantages
Disadvantages
Cellular Reprogramming in Stem Cells
Human Parthenogenetic Stem Cells
Limitations in Stem Cell and Regenerative Therapy
Cancer Stem Cells
Historic Background of Stem Biology
Stem Cell Research
Stem Cell Research Centers
Stem Cell Production
Stem Cell Acquisition
Characterization and Expansion
Maintenance and Storage
Stem Cell Production Economics
Customized Therapy
Overview: Regenerative Medicine

Chapter 4 Market Dynamics
Market Drivers
Increasing Emphasis on Stem Cell Research
Growing Research and Development Activities in Regenerative Medicine 
Rise in Prevalence of Trauma Emergencies and Chronic Diseases
Technological Advancement in Stem Cell Tools and Products
Market Restraints
Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
High Treatment Cost and Operational Inefficiency Associated with Stem Cell Research

Chapter 5 Market Breakdown by Product
Global Stem Cell and Regenerative Medicines Market, by Product
Therapeutic Products
Market Size and Forecast
Cell Therapies
Tissue Engineering
Gene Therapy
Cell Banking
Market Size and Forecast
Market Analysis
Tools and Reagents
Market Size and Forecast
Market Analysis

Chapter 6 Market Breakdown by Application
Global Stem Cell and Regenerative Medicines Market, by Application
Oncology
Market Size and Forecast
Market Analysis
Cardiovascular Disorders
Market Size and Forecast
Market Analysis
Dermatology
Market Size and Forecast
Market Analysis
Orthopedic
Market Size and Forecast
Market Analysis
Central Nervous System Disorders 
Market Size and Forecast
Market Analysis
Diabetes
Market Size and Forecast
Market Analysis
Others
Market Size and Forecast
Market Analysis

Chapter 7 Market Breakdown by Region
Global Market for Stem Cell and Regenerative Medicines, by Region
North America
United States
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific 
South America
Middle East and Africa

Chapter 8 Regulatory Scenario
Stem Cell Regulation
Australia
Brazil
Canada
China
France
Germany
India
Ireland
Israel
Italy
Japan
South Korea
Spain
U.K.
U.S.
European Union

Chapter 9 Patent Analysis
Patent Analysis
Tissue Engineering and Regeneration Patent
Japan Patent Analysis
Europe Patent Analysis
U.S. Patent Analysis
Stem Cell Patents
Patentability of Stem Cell Lines
Policies by Country

Chapter 10 Competitive Landscape
Merger and Acquisitions
Merger and Acquisitions in 2019 (Till April 2019)
Merger and Acquisitions in 2018
Merger and Acquisitions in 2017
Partnerships and Collaborations
Product Launches

Chapter 11 Company Profiles
3DMATRIX
ALDAGEN INC.
ARTERIOCYTE
ATHERSYS INC.
BEIKE BIOTECHNOLOGY CO. LTD.
BIOTIME INC.
BRAINSTORM CELL THERAPEUTICS INC.
BOEHRINGER INGELHEIM GMBH
CALADRIUS BIOSCIENCES INC.
CAPRICOR INC.
CELLERANT THERAPEUTICS INC.
CERAPEDICS INC.
CELLULAR DYNAMICS INTERNATIONAL
CELYAD
CRYOLIFE INC.
CYTORI THERAPEUTICS INC.
DAIICHI SANKYO CO. LTD.
EPISTEM LTD.
GAMIDA CELL LTD.
GILEAD SCIENCES INC.
GLOBALSTEM
HYBRID ORGAN GMBH
INTERNATIONAL STEM CELL CORPORATION
JUVENTAS THERAPEUTICS INC.
MESOBLAST LTD.
NOVARTIS AG
NUO THERAPEUTICS INC. (CYTOMEDIX INC.)
OCATA
ORGANOGENESIS INC. (ADVANCED BIOHEALING)
OSIRIS THERAPEUTICS INC.
PRIMEGEN BIOTECH LLC
RENEURON GROUP
STEM CELLS INC.
STEMEDICA CELL TECHNOLOGIES INC.
STEMINA BIOMARKER DISCOVERY INC.
STEMPEUTICS
TIGENIX NV (A PART OF TAKEDA PHARMACEUTICAL COMPANY LIMITED)
U.S. STEM CELL INC.
VERICEL CORPORATION
VERISTEM
VIACYTE INC.
VITRO DIAGNOSTICS INC.
WICELL RESEARCH INSTITUTE

Chapter 12 Appendix: Abbreviations

Choose License Type

Research Assistance

For Enquiries, Call :

+44-203-322-1521

Email : sales@trendsmarketresearch.com

Send Your Request